Hayvan Sağlığı Araştırmaları 2009 Yılı Program - Tagem

12. ����������������
I.YIL 2.YIL
• Virusun üretilmesi ve liyofilizasyonu • Raf ömrünün belirlenmesi
• Sterilite,
• �������������
• �������������
• ������������������������
• Serolojik ve Virolojik Kontrollerin
������������
13. ������������������
1. ����������� ������ ������ ����� �������� ���� ���� ��� ���� ����������� ����������� ������ ��� ����
production of a polyvalent vaccine for sheep. Onderstepoort J. Vet. Res. 26 (1): 3-15.
2. Anonim (1999) Bluetongue emergency in Bulgaria, Turkey and Greece. In, EMPRES
Transboundary Animal Diseases Bulletin����������
[http://www.fao.org/documents/show_cdr.asp?url_file=/docrep/X3444e/x3444e04.htm]
3. Anonim (2004a) Bluetongue in Croatia. Serological findings in sentinel bovine animals. Follow-
�����������������������������������������������������������������
[http://www.oie.int/eng/info/hebdo/AIS_16.HTM#Sec0]
4. BRÉARD, E., SAILLEAU, C., COUPIER, H.,MURE-RAVAUD, K., HAMMOUMI, S.,
GICQUEL, B., HAMBLIN, C., DUBOURGET, P., ZIENTARA, S. (2003)Comparison of
genome segments 2, 7 and 10 of bluetongue viruses serotype 2 for differentiation between field
isolates and the vaccine strain. Vet. Res. 34: 777-89.
5. CHANNELL, M., STOTT, J.L. (1989). Bluetongue virus propagation and plaque assay: variation
due to medium and serum supplement. J. Virol. Meth. 24: 265-74.
6. ERASMUS, B. J. (1990). Bluetongue virus. In: Virus Infections of Ruminants, Ed: Dinter, Z.,
Morein, B., Elsevier Science Publishers, Chapter 21, p.: 227-237.
7. ERTÜRK, A., ������� ���� ��������� ��� �� ��������� ���� ��������� ������ ������� F.M.
(2004) The current situation of bluetongue in Turkey. Vet. Ital., 40 (3), 137-140
8. European Commision Health Consumer Protection Directorate- General (
Sanco/C3/AH/R19/2000) Possible use of vaccination against Bluetongue in Europe. Scientific
Committee on animal health and animal welfare. Adopte 27 june 2000.
9. ���������� ���� �������� ���� ���������� ���� ������� ���� ��������� ���� �����-
SOSSAH, C., ALBINA, E., SANCHIS, R., PEPIN, M., GUIBERT, J., ZIENTRA, S. (2003).
Studies on the Safety and Immunogenicity of the South African BluetongueVirus Serotype 2
Monovalent Vaccine: Specific Detection of the Vaccine Strain Genome by RT-PCR. J. Vet. Med.
B 50: 316-21.
10. KEMENY, L., DREHLE. (1961). The use of tissue culture- propagated bluetongue virus for
vaccine prepartion. Am. J. Vet. Res. Sep. 921-26.
11. KIRKLAND, P.D., HAWKES, R.A. (2004). A comparisation of laboratory and wild strains of
bluetongue virus- is there any difference and dose it matter? Vet. Ital. 40 (4): 448-55.
12. MANN, N., MANN, S., SINGH, K.P., SAMUEL, A. R., MERTENS, P., Development of reverse
transcriptase-polymerase chain reaction-basedassays and sequencing for typing European strains
of bluetongue virusand differential diagnosis of field and vaccine strains. Vet. Ital. 40 (4): 552-
61.
13. MELLOR, P. S., WITTMANN, E. J. (2002). Bluetongue virus in the mediterranean basin 1998-
2001. Vet J 164(1): 20-37.
14. ���������������������������������������������������������������������������������
ANTHONY, S. J., MANN, S. (2007). Design of primers and use of RT-PCR assays fortyping
European bluetongue virus isolates: differentiation of field and vaccine strains. J.Gen. Virol.
88:2811-23.
15. MARINER J.C., HOUSE A.E., SOLLOD C., MEBUS C.A., (1990). Comparison of the effect of
various stabilizers and lyophilization cycleson the thermostability of a Vero Cell-adapted
rinderpest vaccine. Vet.Microbiol. 21(3): 195-209.
16. MONACO, F., CAMMA, C., SERINI, SAVINI, G. (2006). Differentiation between field and
vaccine strain ofbluetongue virus serotype 16. Vet. Microb. 166: 45-52.
140